The future just got a UK passport.
In a bold expansion beyond U.S. borders, Neuralink—the brain-computer interface (BCI) startup founded by Elon Musk—has launched its first European clinical trial. The UK has become ground zero for testing the next phase of mind-controlled technology, as seven British patients with severe paralysis prepare to have a coin-sized chip implanted directly into their brains.
Let’s be clear: this isn’t a sci-fi plot. It’s happening now.
Working alongside the University College London Hospitals and Newcastle upon Tyne Hospitals, Neuralink is testing whether its N1 chip can allow paralyzed individuals to control digital devices with nothing but thought. Type an email? Open an app? Play a game? All without lifting a finger. For the right patient, this could be a leap from locked-in to logged-on.
Continue reading… “Neuralink Goes Global: Elon Musk’s Brain Chip Heads to the UK for High-Stakes Human Trials”